PneumoADIP

Pneumococcal vaccines Accelerated Development and Introduction Plan (PnemoADIP) is a small, dedicated team based at Johns Hopkins Bloomberg School of Public Health and is supported by a $30 million grant from the Global Alliance for Vaccines and Immunization. Its mission is to improve child survival and health by accelerating the evaluation of and access to new, lifesaving pneumococcal vaccines for the world's children.

PneumoADIP aims to achieve its goals through partnerships with countries, donors, academia, international organizations and industry. PneumoADIP coordinates its activities through a strategic alliance with the World Health Organization.

External link

 * PneumoADIP - Pneumococcal vaccines Accelerated Development and Introduction Plan